Skip to main content

Table 1 Baseline Demographic, Clinical and HRQL Characteristics According to Treatment Intensitya

From: Health-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetes

 

Diet n = 69 (17.5%)

Oral Medication n = 190 (48.2%)

Insulin n = 107 (27.2%)

Age – Mean (SD)

60.13 (12.20)

63.44(12.78)

62.67 (12.10)

Sex, Males – n (%)

34(49.3)

81 (42.6)

45 (42.1)

Income – n (%)

   

   less than $5000

4 (5.8)

16 (8.4)

12 (11.2)

   $5000 to $19999

18 (26.1)

64 (33.7)

39(36.4)

   $20000 to 399999

21 (30.4)

45 (23.7)

24(22.4)

   greater than $40000

19 (27.5)

48 (25.3)

18(16.8)

Marital status, Currently married – n (%)

45 (65.2)

121 (63.7)

58 (54.2)

First Nations Status – n (%)

17 (24.6)

38 (20.0)

32 (29.9)

Graduated high school – n (%)

44 (33.8)

66 (34.7)

30 (28.0)

Main activityb – n (%)

   

   Retired

25 (36.2)

85 (44.7)

42 (39.3)

   Working for pay

30 (43.4)

55 (29.0)

24 (22.5)

   Other

13 (18.7)

40 (22.4)

41 (38.3)

Duration of diabetesc (years) – Mean (SD)

3.17 (5.75)

6.28 (6.19)

14.89 (9.46)

HbA1c (%) c – Mean (SD)

0.064 (0.011)

0.073 (0.015)

0.082 (0.017)

Body Mass Index (kg/m2) – Mean (SD)

34.65 (6.19)

32.48 (6.93)

33.89 (7.17)

Total Cholesterol (mmol/L) – Mean (SD)

5.02 (0.92)

4.88 (0.97)

5.05 (1.06)

Systolic Blood Pressure (mmHg) – Mean (SD)

129.62 (17.45)

131.88 (17.12)

132.66 (22.39)

Diastolic Blood Pressure (mmHg) – Mean (SD)

77.74 (12.99)

76.46 (10.68)

74.13 (11.96)

  1. a Table includes those subjects with complete data on treatment regimen for diabetes (N = 366/372) b Chi-Square p-value = 0.001 c Omnibus ANOVA had p < 0.001 and all post-hoc pair-wise comparisons had p ≤ 0.01